Emend 125 mg Oral Suspension (Aprepitant Bottles) 125mg

EMEND 125 MG ORAL SUSPENSION contains Aprepitant, a medication used to prevent nausea and vomiting. It is commonly prescribed for patients undergoing chemotherapy. This suspension form is convenient for precise dosing.

Strength

125mg

Pack Size

Storage

Ambient

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Aprepitant is primarily used to prevent nausea and vomiting caused by chemotherapy treatments. It may also be prescribed for postoperative nausea and vomiting prevention. The 125 mg strength is often the initial dose in a treatment regimen. Patients often ask, 'what is Aprepitant used for' to understand its role in managing side effects.

Side Effects

Aprepitant works by blocking certain natural substances in the body that trigger nausea and vomiting. Users may notice reduced queasiness and fewer episodes of vomiting after starting treatment. Effects can vary, and some individuals may experience mild drowsiness or dizziness.

Precautions & Warnings

Keep this medication at room temperature and away from moisture or heat. Shake the bottle well before each use to ensure proper dosing. Avoid using if the suspension appears discolored or contains particles. Always follow the handling instructions provided with the medication.

Avoid Interactions

Aprepitant may interact with other medications, including certain blood thinners, antifungals, and antidepressants. Alcohol and sedatives can increase drowsiness when combined with this drug. Consult a healthcare provider before mixing with other substances to avoid potential interactions.

Frequently Asked Questions

Store at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use.

Aprepitant can be taken with or without food. Follow your healthcare provider's instructions for the best results.

If you miss a dose, take it as soon as you remember. If it's almost time for the next dose, skip the missed one and continue your regular schedule.

Aprepitant is not typically prescribed for children unless directed by a healthcare professional. Always consult a doctor for pediatric use.

Some users may experience drowsiness or dizziness. Avoid driving or operating machinery if you feel these effects.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.